Cargando…
Management of Dermatologic Toxicities Associated With Targeted Therapy
Autor principal: | Lacouture, Mario E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679053/ https://www.ncbi.nlm.nih.gov/pubmed/29152401 |
Ejemplares similares
-
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
por: Lacouture, Mario E., et al.
Publicado: (2011) -
Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
por: Lacouture, Mario, et al.
Publicado: (2018) -
Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
por: Lacouture, Mario E., et al.
Publicado: (2017) -
Advanced Care Provider and Nursing Approach to Assessment and Management of Immunotherapy-Related Dermatologic Adverse Events
por: Ciccolini, Kathryn, et al.
Publicado: (2017) -
Dermatologic events from EGFR inhibitors: the issue of the missing patient voice
por: Tischer, Bernd, et al.
Publicado: (2016)